{"altmetric_id":7862920,"counts":{"readers":{"mendeley":268,"citeulike":1,"connotea":0},"total":{"posts_count":2},"news":{"unique_users_count":1,"unique_users":["medscape"],"posts_count":1},"f1000":{"unique_users_count":1,"unique_users":["F1000Prime"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa5113cf058f610003250","authors":["Michael J. Elman","Lloyd Paul Aiello","Roy W. Beck","Neil M. Bressler","Susan B. Bressler","Allison R. Edwards","Frederick L. Ferris","Scott M. Friedman","Adam R. Glassman","Kellee M. Miller","Ingrid U. Scott","Cynthia R. Stockdale","Jennifer K. Sun","The Diabetic Retinopathy Clinical Research Network","Frederick L. Ferris, III","Elman MJ","Aiello LP","Beck RW","Bressler NM","Bressler SB","Edwards AR","Ferris FL 3rd","Friedman SM","Glassman AR","Miller KM","Scott IU","Stockdale CR","Sun JK"],"doi":"10.1016\/j.ophtha.2010.02.031","endpage":"1077.e35","first_seen_on":"2016-05-20T07:20:07+00:00","issns":["0161-6420","1549-4713","01616420"],"issue":"6","journal":"Ophthalmology","last_mentioned_on":1473796478,"links":["http:\/\/dx.doi.org\/10.1016\/j.ophtha.2010.02.031","http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2937272\/"],"pdf_url":"http:\/\/www.aaojournal.org\/article\/S0161642010002435\/pdf","pmcid":"PMC2937272","pmid":"20427088","pubdate":"2010-04-28T00:00:00+00:00","publisher":"Elsevier","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Ophthalmology And Optometry","scheme":"era"},{"name":"Public Health And Health Services","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1064","subjects":["ophthalmology"],"title":"Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema","type":"article","uri":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642010002435","volume":"117","mendeley_url":"http:\/\/www.mendeley.com\/research\/randomized-trial-evaluating-ranibizumab-plus-prompt-deferred-laser-triamcinolone-plus-prompt-laser-d"},"altmetric_score":{"score":8,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":8},"context_for_score":{"all":{"total_number_of_other_articles":8372629,"mean":7.0578283965246,"rank":1109064,"this_scored_higher_than_pct":86,"this_scored_higher_than":7239963,"rank_type":"exact","sample_size":8372629,"percentile":86},"similar_age_3m":{"total_number_of_other_articles":273432,"mean":11.654062780006,"rank":50307,"this_scored_higher_than_pct":81,"this_scored_higher_than":222618,"rank_type":"exact","sample_size":273432,"percentile":81},"this_journal":{"total_number_of_other_articles":2586,"mean":10.676834816248,"rank":309,"this_scored_higher_than_pct":87,"this_scored_higher_than":2272,"rank_type":"exact","sample_size":2586,"percentile":87},"similar_age_this_journal_3m":{"total_number_of_other_articles":96,"mean":46.022231578947,"rank":21,"this_scored_higher_than_pct":78,"this_scored_higher_than":75,"rank_type":"exact","sample_size":96,"percentile":78}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":3,"Professor > Associate Professor":23,"Librarian":4,"Researcher":53,"Student  > Doctoral Student":12,"Student  > Ph. D. Student":32,"Student  > Postgraduate":31,"Student  > Master":31,"Other":50,"Student  > Bachelor":16,"Lecturer":4,"Lecturer > Senior Lecturer":4,"Professor":5},"by_discipline":{"Medicine and Dentistry":195,"Social Sciences":4,"Physics and Astronomy":1,"Psychology":1,"Mathematics":2,"Unspecified":9,"Pharmacology, Toxicology and Pharmaceutical Science":2,"Engineering":3,"Chemistry":2,"Neuroscience":1,"Economics, Econometrics and Finance":4,"Agricultural and Biological Sciences":33,"Computer Science":3,"Business, Management and Accounting":1,"Nursing and Health Professions":3,"Biochemistry, Genetics and Molecular Biology":4}}},"geo":{"mendeley":{"HU":2,"US":1,"GB":2,"PT":3,"ES":3,"RU":2,"CA":1,"AT":2,"TR":2,"DK":2,"IT":2,"MX":1,"IL":3}}},"posts":{"f1000":[{"title":"Recommended in F1000 Prime","url":"https:\/\/f1000.com\/prime\/724709443","license":"public","citation_ids":[7862920],"posted_on":"2016-05-17T00:00:00+00:00","f1000_classes":[],"f1000_score":"3"}],"news":[{"title":"Predicting Anti-VEGF Response in Diabetic Macular Edema","url":"http:\/\/ct.moreover.com\/?a=27945572943&p=1pl&v=1&x=t-JA2JTk3J_PqDVUHBPS2w","license":"public","citation_ids":[7862920],"posted_on":"2016-09-13T19:54:38+00:00","summary":"COPENHAGEN \u2014 For patients with diabetic macular edema, visual acuity at 1 and 3 years is better if central retinal thickness has decreased by at least 20% after three monthly injections of the anti-VEGF ranibizumab, an analysis of the DRCR.net\u2026","author":{"name":"Medscape","url":"http:\/\/medscape.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/055\/normal\/medscape.png?1369846939"}}]}}